Title:The Application of Stimuli-responsive Nanocarriers for Targeted Drug Delivery
VOLUME: 17 ISSUE: 20
Author(s):Mengxue Zhou, Kaikai Wen, Ying Bi, Huiru Lu, Jun Chen*, Yi Hu and Zhifang Chai
Affiliation:CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Multi-disciplinary Research Division, Institute of High Energy Physics, Chinese Academy of Sciences (CAS), Beijing 100049, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Multi-disciplinary Research Division, Institute of High Energy Physics, Chinese Academy of Sciences (CAS), Beijing 100049, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Multi-disciplinary Research Division, Institute of High Energy Physics, Chinese Academy of Sciences (CAS), Beijing 100049, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Multi-disciplinary Research Division, Institute of High Energy Physics, Chinese Academy of Sciences (CAS), Beijing 100049, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Multi-disciplinary Research Division, Institute of High Energy Physics, Chinese Academy of Sciences (CAS), Beijing 100049, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Multi-disciplinary Research Division, Institute of High Energy Physics, Chinese Academy of Sciences (CAS), Beijing 100049, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Multi-disciplinary Research Division, Institute of High Energy Physics, Chinese Academy of Sciences (CAS), Beijing 100049
Keywords:Stimuli-response, Nanoparticles, Drug delivery, Tumor microenvironment, Chemotherapy.
Abstract:Nanocarriers are widely used for delivering drugs to tumors and are progressing in a stable
trend, because malignant tumors remain a major health burden throughout the world and effective
therapeutic strategies are urgently needed. Furthermore, as an integrated platform, nanocarriers have
the potential to dramatically improve cancer diagnosis, imaging, and therapy, while reducing the toxicity
associated with the current approaches. Significantly, intelligent nanocarriers are the new generation
of the nanocarriers, exhibiting superior tumor targeting and improved therapeutic efficacy. In
this review, we discuss recent development in the design of nanoscale stimuli-responsive systems
which will be able to control drug biodistribution in response to specific stimuli, either exogenous or
endogenous. Meanwhile, the recent progress in engineering intelligent and versatile nanomaterials for
targeting the tumor microenvironment is summarized.
